Transparency Market Research Report Added "Peptide Therapeutics Market" to its database.

Albany, NY -- (SBWire) -- 10/12/2015 --The global peptide therapeutics market report provides detailed analysis, market size, and forecast for therapeutic peptides approved for various indications. The market is studied from four major perspectives: applications, route of administration, marketing status, and geography. Application segments of the global peptide therapeutics market have been further sub-segmented by major branded peptide drugs approved by regulatory authorities across the globe. Various applications considered in the report include metabolic disorders, hematological disorders, cancer, cardiovascular disorders, central nervous system disorders, infection, gastrointestinal disorders, respiratory disorders, acromegaly, and others. Market size and forecast for leading drugs such as Angiomax, Copaxone, Forteo, Sandostatin, Velcade, Victoza, and Zoladex has been included along with in-depth market analysis. Segmentation by marketing status explains the impact of generic drugs on the overall peptide therapeutics market. Further, market segmentation of peptide drugs by route of administration provides quantitative insights into the growing demand for convenient methods for peptide drug administration. Details on peptide drug approvals, patent expiry, mergers, acquisitions, strategic agreements, disease prevalence and other major events have been included in respective market segments.

Browse Full Report: http://www.transparencymarketresearch.com/peptide-therapeutics-market.html

The global peptide therapeutics market report provides market estimation and forecast for more than fifteen branded peptide drugs in the market. Further, the market is also segmented by major geographical regions, which include North America, Europe, Asia Pacific and Rest of the World. A list of pipeline drugs has also been provided in the report. This list includes potential peptide drugs in phases I, II, and III of clinical development.

Emerging trends in global peptide API production, such as development of new peptide API production technologies and strategic agreements in peptide API production have been discussed. The report also profiles key peptide API suppliers. An overview of regulatory policies has also been provided in the global peptide therapeutics market report. Based on our in-depth analysis and comprehensive market study, key factors driving and restraining the market have been discussed. A detailed event impact analysis considers regulatory approvals, patent expiry of major drugs, drug recalls and other factors in the peptide therapeutics market. The research study also incorporates the competitive scenario in these regions, where market share of seven major players in 2013 has also been provided. Relevant recommendations have been provided for new entrants as well as existing market players to help them establish a strong presence in the market and increase their share. Fifteen major players have been profiled which include Amgen, Inc., AstraZeneca plc, Bachem Holding AG, CordenPharma International GmbH, Eli Lilly & Co., Ipsen S.A., Lonza, Inc., Merck & Co., Novartis AG, Novo Nordisk A/S, PolyPeptide Group, Roche Holdings AG, Sanofi, Takeda Pharmaceutical Company Limited, and Teva Pharmaceutical Industries Limited. The 104 pages global peptide therapeutics market report includes 30 figures and charts, and 14 tables.

Get Free Sample: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=418

Market size and forecast in terms of USD million for each segment in the global peptide therapeutics market has been provided for the period 2012 to 2020, considering 2012 and 2013 as the base years. The report also provides the compounded annual growth rate (CAGR %) for each market segment for the forecast period 2014 to 2020. The peptide therapeutics market has been estimated using a bottom-up approach, where market size estimates for each drug have been summed-up to arrive at the total market size. Market forecasts have been derived considering the effect of generic drug approvals, drug recalls, disease prevalence, patent term extension, box warning and various other factors. Inputs from industry experts and key opinion leaders have validated and further refined our market estimates.

Read Full Press Release: http://www.transparencymarketresearch.com/pressrelease/peptide-therapeutics-market.htm

The global peptide therapeutics market has been segmented as below:
Global Peptide Therapeutics Market, by Application
Cancer
Zoladex (goserelin)
Velcade (bortezomib)
Lupron/ Enantone/ Eligard (leuprorelin)
Others
Cardiovascular
Angiomax (bivalirudin)
Integrilin (eptifibatide)
Central Nervous System
Copaxone (glatiramer)
Metabolic Disorders
Victoza (liraglutide)
Byetta (exenatide)
Others
Infection
Incivek (telaprevir)
Victrelis (boceprevir)
Hematological Disorders
Firazyr (icatibant)
Kalbitor (ecallantide)
Gastrointestinal Disorders
Gattex (teduglutide)
Linzess (linaclotide)
Respiratory Disorders
Acromegaly
Other Applications
Global Peptide Therapeutics Market, by Route of Administration
Parenteral
Oral
Global Peptide Therapeutics Market, by Marketing Status
Branded
Generic
Global Peptide Therapeutics Market, by Geography
North America
Europe
Asia Pacific
Rest of the World

About Transparency Market Research (TMR)
Transparency Market Research (TMR) is a U.S.-based provider of syndicated research, customized research, and consulting services. TMR's global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.

Contact us:
Mr. Nachiket
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/